BSF Enterprise Targets £15 Million Equity Raise to Advance Lab‑Grown Leather and Bio‑Tissue Projects
BSF Enterprise PLC, a company specializing in tissue-engineered materials, has announced plans for a £15 million equity fundraise to accelerate the commercialization of its core technologies in lab-grown leather, corneal repair, and cell culture media for biomedical applications. The investment is part of a broader strategy to expand the company’s capabilities and market presence in these emerging sectors. The fundraise, which includes a combination of convertible loan notes and warrants, …